News Announcement

Marksans Pharma: Audited Financial Results For The Quarter And Financial Year Ended 31St March 2022 And Auditors Report Thereon

In terms of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 kindly find enclosed herewith Audited Financial Results (both Standalone and Consolidated) for the quarter and financial year ended 31st March 2022 which have been approved by the Board of Directors at its meeting held today i.e. 30th May 2022 along with Auditors Report thereon.The meeting commenced at 7:17 p.m. and concluded at 8:00 p.m.In this connection we hereby confirm that the Statutory Auditors have given their reports on the Audited Annual Financial Results for the financial year ended 31st March 2022 (both Standalone and Consolidated) with unmodified opinion.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.


Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds